Collect Product
Product Details
Synonyms
CD33, SIGLEC3, gp67
Source
Cynomolgus Siglec-3, His Tag (CD3-C52H4) is expressed from human 293 cells (HEK293). It contains AA Met 16 - Leu 228 (Accession # XP_045235686.1).
Predicted N-terminus: Met 16
Request for sequenceMolecular Characterization
Other Tags and Version Biotin & Other Labeled Version
This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 25.7 kDa. The protein migrates as 38-43 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.
Endotoxin
Less than 1.0 EU per μg by the LAL method / rFC method.
Purity
>90% as determined by SDS-PAGE.
>90% as determined by SEC-MALS.
Formulation
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
Reconstitution
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
Storage
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- -20°C to -70°C for 12 months in lyophilized state;
- -70°C for 3 months under sterile conditions after reconstitution.
ACRO Quality Management System
Kunden haben auch angesehen
Data Display
SDS-PAGE
Cynomolgus Siglec-3, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90% (With Star Ribbon Pre-stained Protein Marker).
SEC-MALS
The purity of Cynomolgus Siglec-3, His Tag (Cat. No. CD3-C52H4) is more than 90% and the molecular weight of this protein is around 40-60 kDa verified by SEC-MALS.
Report
User Reviews Publish Comment
Background Introduction
Frontier Progress
Drug Development Progress- English Name：
Myeloid cell surface antigen CD33
- Category：
- Listed Drugs Count：
1 Details
- Clinical Drugs Count：
44 Details
- Highest R&D Stage：
Approved
Contact Us
Drug Candidate Licensing
